COVGUARD LIMITED

Active Cheltenham

Manufacture of pharmaceutical preparations

2 employees website.com
Manufacture of pharmaceutical preparations
C

COVGUARD LIMITED

Manufacture of pharmaceutical preparations

Founded 28 Jun 2021 Active Cheltenham, England 2 employees website.com
Manufacture of pharmaceutical preparations
Accounts Submitted 12 Nov 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 1 Jul 2025 Next due 11 Jul 2026 1 month remaining
Net assets £100 £0 2024 year on year
Total assets £100 £0 2024 year on year
Total Liabilities £0
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Festival House Jessop Avenue Cheltenham GL50 3SH England

Full company profile for COVGUARD LIMITED (13480742), an active company based in Cheltenham, England. Incorporated 28 Jun 2021. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type dormant
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

N/A

Net Assets

£100.00

Total Liabilities

N/A

Turnover

N/A

Employees

2

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 1 resigned
Status
Daniel Llewellyn ThomasDirectorBritishUnited Kingdom5517 Nov 2022Active

Shareholders

Shareholders (1)

Covestus Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Covestus Limited

United Kingdom

Active
Notified 28 Jun 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Group Structure

Group Structure

COVGUARD LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Nov 2025AccountsAnnual accounts made up to 31 Dec 2024
1 Jul 2025AddressChange Registered Office Address Company With Date Old Address New Address
1 Jul 2025Persons With Significant ControlChange to Covestus Limited as a person with significant control on 24 Jun 2025
1 Jul 2025OfficersChange to director Mr Daniel Llewellyn Thomas on 24 Jun 2025
1 Jul 2025Confirmation StatementConfirmation statement made on 27 Jun 2025 with no updates
12 Nov 2025 Accounts

Annual accounts made up to 31 Dec 2024

1 Jul 2025 Address

Change Registered Office Address Company With Date Old Address New Address

1 Jul 2025 Persons With Significant Control

Change to Covestus Limited as a person with significant control on 24 Jun 2025

1 Jul 2025 Officers

Change to director Mr Daniel Llewellyn Thomas on 24 Jun 2025

1 Jul 2025 Confirmation Statement

Confirmation statement made on 27 Jun 2025 with no updates

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

6 months ago on 12 Nov 2025

Change Registered Office Address Company With Date Old Address New Address

10 months ago on 1 Jul 2025

Change to Covestus Limited as a person with significant control on 24 Jun 2025

10 months ago on 1 Jul 2025

Change to director Mr Daniel Llewellyn Thomas on 24 Jun 2025

10 months ago on 1 Jul 2025

Confirmation statement made on 27 Jun 2025 with no updates

10 months ago on 1 Jul 2025